AppetiteControl™ is an active implant under development to treat obesity using a completely new principle of treatment to control appetite. AppetiteControl is designed to use the company's eHealth platform enabling to control appetite with a remote control or a fully automatic system based on the patient's food intake, which is monitored and sent to the caregiver. This product is targeted to be launched in 2022.